Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 343

1.

Heterogeneity of mammary lesions represent molecular differences.

Namba R, Maglione JE, Davis RR, Baron CA, Liu S, Carmack CE, Young LJ, Borowsky AD, Cardiff RD, Gregg JP.

BMC Cancer. 2006 Dec 5;6:275.

2.

Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines.

Zanazzi C, Hersmus R, Veltman IM, Gillis AJ, van Drunen E, Beverloo HB, Hegmans JP, Verweij M, Lambrecht BN, Oosterhuis JW, Looijenga LH.

Genes Chromosomes Cancer. 2007 Oct;46(10):895-908.

PMID:
17620293
3.

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T, Pejavar S, Mehta K, Carroll P, Simko JP, Waldman FM.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):7012-22.

4.

Genome signatures of colon carcinoma cell lines.

Kleivi K, Teixeira MR, Eknaes M, Diep CB, Jakobsen KS, Hamelin R, Lothe RA.

Cancer Genet Cytogenet. 2004 Dec;155(2):119-31.

PMID:
15571797
5.

Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes.

Orsetti B, Nugoli M, Cervera N, Lasorsa L, Chuchana P, Ursule L, Nguyen C, Redon R, du Manoir S, Rodriguez C, Theillet C.

Cancer Res. 2004 Sep 15;64(18):6453-60.

6.

Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.

Namba R, Young LJ, Abbey CK, Kim L, Damonte P, Borowsky AD, Qi J, Tepper CG, MacLeod CL, Cardiff RD, Gregg JP.

Clin Cancer Res. 2006 Apr 15;12(8):2613-21.

7.

A novel method for gene expression mapping of metastatic competence in human bladder cancer.

Wu Z, Siadaty MS, Riddick G, Frierson HF Jr, Lee JK, Golden W, Knuutila S, Hampton GM, El-Rifai W, Theodorescu D.

Neoplasia. 2006 Mar;8(3):181-9.

8.

Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH.

Selvarajah S, Yoshimoto M, Ludkovski O, Park PC, Bayani J, Thorner P, Maire G, Squire JA, Zielenska M.

Cytogenet Genome Res. 2008;122(1):5-15. doi: 10.1159/000151310. Epub 2008 Oct 14.

PMID:
18931480
9.

Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.

Rodenhiser DI, Andrews J, Kennette W, Sadikovic B, Mendlowitz A, Tuck AB, Chambers AF.

Breast Cancer Res. 2008;10(4):R62. doi: 10.1186/bcr2121. Epub 2008 Jul 18.

10.
11.
12.

Analysis of copy number changes suggests chromosomal instability in a minority of large colorectal adenomas.

Jones AM, Thirlwell C, Howarth KM, Graham T, Chambers W, Segditsas S, Page KM, Phillips RK, Thomas HJ, Sieber OM, Sawyer EJ, Tomlinson IP.

J Pathol. 2007 Nov;213(3):249-56.

PMID:
17893889
13.

Molecular markers in ductal carcinoma in situ of the breast.

Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, Richardson A, Cooper A, Strausberg R, Riggins GJ, Schnitt S, Gabrielson E, Gelman R, Polyak K.

Mol Cancer Res. 2003 Mar;1(5):362-75.

14.

Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.

Ferreira BI, García JF, Suela J, Mollejo M, Camacho FI, Carro A, Montes S, Piris MA, Cigudosa JC.

Haematologica. 2008 May;93(5):670-9. doi: 10.3324/haematol.12221. Epub 2008 Mar 26.

15.

Chromosome 22 array-CGH profiling of breast cancer delimited minimal common regions of genomic imbalances and revealed frequent intra-tumoral genetic heterogeneity.

Benetkiewicz M, Piotrowski A, Díaz De Ståhl T, Jankowski M, Bala D, Hoffman J, Srutek E, Laskowski R, Zegarski W, Dumanski JP.

Int J Oncol. 2006 Oct;29(4):935-45.

PMID:
16964389
16.

Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis.

Choi YW, Bae SM, Kim YW, Lee HN, Kim YW, Park TC, Ro DY, Shin JC, Shin SJ, Seo JS, Ahn WS.

Int J Gynecol Cancer. 2007 May-Jun;17(3):687-96.

PMID:
17504382
17.

Integrated analysis of copy number alteration and RNA expression profiles of cancer using a high-resolution whole-genome oligonucleotide array.

Jung SH, Shin SH, Yim SH, Choi HS, Lee SH, Chung YJ.

Exp Mol Med. 2009 Jul 31;41(7):462-70. doi: 10.3858/emm.2009.41.7.051.

18.

Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome.

Katoh H, Shibata T, Kokubu A, Ojima H, Loukopoulos P, Kanai Y, Kosuge T, Fukayama M, Kondo T, Sakamoto M, Hosoda F, Ohki M, Imoto I, Inazawa J, Hirohashi S.

J Hepatol. 2005 Nov;43(5):863-74. Epub 2005 Jul 5.

PMID:
16139920
19.

Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome.

Spitz R, Oberthuer A, Zapatka M, Brors B, Hero B, Ernestus K, Oestreich J, Fischer M, Simon T, Berthold F.

Genes Chromosomes Cancer. 2006 Dec;45(12):1130-42.

PMID:
16958102
20.

Karyotypic evolution of four novel mouse mammary carcinoma cell lines. Identification of marker chromosomes by fluorescence in situ hybridization.

Fabris V, Lamb CA, Keck C, Aldaz CM, Merani S, Lanari C.

Cancer Genet Cytogenet. 2003 Apr 1;142(1):36-45.

PMID:
12660031

Supplemental Content

Support Center